- Report
- September 2025
- 150 Pages
Global
From €3992EUR$4,450USD£3,413GBP
- Report
- April 2026
- 231 Pages
Global
From €3500EUR$4,180USD£3,097GBP
- Report
- October 2025
- 163 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- March 2026
- 155 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- October 2025
- 90 Pages
Global
From €4037EUR$4,500USD£3,451GBP
- Report
- October 2025
- 48 Pages
Global
From €1076EUR$1,200USD£920GBP
- Report
- December 2025
- 150 Pages
United States
From €4351EUR$4,850USD£3,719GBP
- Report
- August 2019
- 264 Pages
Global
From €3584EUR$3,995USD£3,064GBP
- Report
- December 2024
- 332 Pages
Global
From €3765EUR$4,197USD£3,219GBP
- Report
- February 2024
- 270 Pages
Global
From €5266EUR$6,076USD£4,350GBP
- Report
- May 2024
- 311 Pages
Global
From €5266EUR$6,076USD£4,350GBP
- Report
- December 2022
- 425 Pages
Global
From €4782EUR$5,517USD£3,950GBP
- Report
- October 2022
- 213 Pages
Global
From €4782EUR$5,517USD£3,950GBP
- Report
- June 2021
- 193 Pages
Global
From €4305EUR$4,799USD£3,680GBP
- Report
- March 2025
- 1048 Pages
Global
From €4305EUR$4,799USD£3,680GBP
- Report
- January 2024
- 270 Pages
Global
From €4305EUR$4,799USD£3,680GBP
- Report
- July 2023
- 205 Pages
Global
From €5292EUR$5,899USD£4,524GBP
- Report
- August 2022
- 121 Pages
Global
From €1165EUR$1,299USD£996GBP
- Report
- April 2022
- 121 Pages
Global
From €1704EUR$1,899USD£1,456GBP
- Report
- April 2022
- 131 Pages
Global
From €1165EUR$1,299USD£996GBP

CRISPR Therapeutics is a rapidly growing field within the genomics market. It is a gene-editing technology that uses a modified version of the CRISPR-Cas9 system to modify or replace genes in a living organism. This technology has the potential to revolutionize the way diseases are treated, as it can be used to target and modify specific genes that are responsible for certain diseases. It can also be used to create new treatments for diseases that have no existing treatments.
CRISPR Therapeutics has been used to develop treatments for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. It has also been used to create new treatments for rare diseases, as well as to develop new therapies for existing diseases.
Companies in the CRISPR Therapeutics market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences. These companies are working to develop treatments for a variety of diseases, as well as to create new therapies for existing diseases. Show Less Read more